Streetbeat News

PTIX

Protagenic Therapeutics, Inc.

https://www.protagenic.com

Industry

Biotechnology

Protagenic Therapeutics, Inc., a biopharmaceutical company, engages in the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. Its lead compound is PT00114, a synthetic form of teneurin carboxy-terminal associated peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. The company is based in New York, New York.

Open

0.62

Mkt cap

3.9M

Volume

166K

High

0.66

P/E Ratio

-0.40

52-wk high

1.87

Low

0.54

Div yield

N/A

52-wk low

0.49

The article highlights the pre-market movements of various healthcare stocks on Tuesday. Notable gainers include Silexion Therapeutics, Adagio Medical Holdings, and Chromocell Therapeutics, while significant losers include Shattuck Labs, IGM Biosciences, and Applied DNA Sciences.

Portfolio Pulse from Benzinga Insights

October 01, 2024 | 12:07 pm

In Monday's pre-market session, several healthcare stocks experienced significant movements. Prime Medicine, Traws Pharma, and Tharimmune saw notable gains, while Ensysce Biosciences and Corvus Pharma faced declines. Earnings reports influenced some stock movements.

Portfolio Pulse from Benzinga Insights

September 30, 2024 | 12:06 pm

Exicure, Inc. (NASDAQ:XCUR) shares surged over 49% in pre-market trading after the company entered into debt-for-equity exchange agreements and regained Nasdaq compliance. Other notable pre-market movers include NuCana plc (NASDAQ:NCNA) with a 94.4% gain due to positive Phase 2 study data, and Dermata Therapeutics, Inc. (NASDAQ:DRMA) rising 73.4%. On the downside, Rafael Holdings, Inc. (NYSE:RFL) fell 40.1% after previous gains.

Portfolio Pulse from Avi Kapoor

September 16, 2024 | 10:07 am

Champions Oncology (NASDAQ:CSBR) shares surged over 13% in pre-market trading after reporting better-than-expected Q1 earnings. Other notable pre-market movers include Smart for Life, Protagenic Therapeutics, and NETGEAR, with significant gains, while Ryde Group and Syra Health saw substantial declines.

Portfolio Pulse from Avi Kapoor

September 12, 2024 | 9:46 am

The article highlights significant intraday movements in health care stocks on Thursday. Notable gainers include OneMedNet, Renovaro, Altamira Therapeutics, Purple Biotech, P3 Health Partners, and Qilian Intl Hldg Gr. On the losing side, SILO Pharma, Cue Health, Protagenic Therapeutics, Cytokinetics, SAB Biotherapeutics, and DermTech experienced declines.

Portfolio Pulse from Benzinga Insights

May 23, 2024 | 4:31 pm

Protagenic Therapeutics shares are trading lower after the company reported safety data from the single dose portion of its Phase 1 trial involving PT00114.

Portfolio Pulse from Benzinga Newsdesk

May 22, 2024 | 5:01 pm

Protagenic Therapeutics reported safety data from the single dose portion of its Phase 1 trial involving PT00114, with no clinically-relevant adverse events. The multiple dose portion of the trial is set to commence.

Portfolio Pulse from Benzinga Newsdesk

May 22, 2024 | 1:03 pm

In Friday's pre-market session, several healthcare stocks showed significant movement. Tevogen Bio Holdings (TVGN) led the gainers with a 75.3% increase, while Processa Pharma (PCSA) experienced the largest drop among the losers, falling 15.6%. Other notable movers included Cryo-Cell International (CCEL) and Moleculin Biotech (MBRX) with substantial gains, and SCWorx (WORX) and Nuwellis (NUWE) with notable losses.

Portfolio Pulse from Benzinga Insights

April 26, 2024 | 12:06 pm

In Thursday's intraday session, several healthcare stocks experienced significant movements. Aclarion, Processa Pharma, Akso Health Group, Eyenovia, Predictive Oncology, and IMAC Holdings were among the gainers, with Aclarion leading by a 66.7% increase. On the downside, Cyclacel Pharmaceuticals, Organogenesis Holdings, Xylo Technologies, Protagenic Therapeutics, American Oncology Network, and INVO Bioscience saw notable declines, with Cyclacel Pharmaceuticals dropping by 33.1%.

Portfolio Pulse from Benzinga Insights

April 25, 2024 | 4:31 pm

In Tuesday's intraday session, several healthcare stocks experienced significant movements. VolitionRX, Palisade Bio, Kintara Therapeutics, Protagenic Therapeutics, BIMI Intl Medical, and NKGen Biotech were among the gainers, with increases ranging from 20.4% to 33.6%. Conversely, Abeona Therapeutics, Rezolute, Jaguar Health, Adlai Nortye, Sunshine Biopharma, and Portage Biotech saw declines between 12.49% and 52.3%.

Portfolio Pulse from Benzinga Insights

April 23, 2024 | 4:31 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.